Literature DB >> 10630257

Commentary on PBT-1 study of high-dose consolidation versus standard therapy in metastatic breast cancer.

R Livingston1, J Crowley.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10630257

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  2 in total

1.  High-dose chemotherapy of cyclophosphamide, thiotepa, and carboplatin (CTCb) followed by autologous stem-cell transplantation for metastatic breast cancer patients: a 6-year follow-up result.

Authors:  Hee-Jung Sohn; Sang-Hee Kim; Gyeong-Won Lee; Shin Kim; Hye Jin Kang; Jin-Hee Ahn; Sung-Bae Kim; Sang-We Kim; Woo Kun Kim; Cheolwon Suh
Journal:  Cancer Res Treat       Date:  2005-02-28       Impact factor: 4.679

2.  High-dose sequential epirubicin and cyclophosphamide with peripheral blood stem cell support for advanced breast cancer: results of a phase II study.

Authors:  P H Cottu; J M Extra; M Espie; J P Marolleau; A de Roquancourt; J Makke; J M Miclea; V Laurence; D Mayeur; F Lerebours; C Cuvier; M Marty
Journal:  Br J Cancer       Date:  2001-11-02       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.